Literature DB >> 20596651

Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.

Rania Georges1, Hassan Adwan, Maria Zhivkova, Ergül Eyol, Frank Bergmann, Martin R Berger.   

Abstract

Colorectal cancer accounts for 11% of all cancers and is the second most frequent cause of cancer-related death, with the majority of deaths attributable to hepatic metastasis. The main aim of the study was to investigate changes which occur in CC531 rat colon adenocarcinoma cells and are instrumental to the metastatic phenotype after homing to the liver. RT-PCR and Western blotting were used to detect the expression of certain proteins, transcription factors and enzymes, which are intimately linked to colorectal metastasis. These included osteopontin (OPN), bone sialoprotein ll (BSP ll), Runx2, Hoxc8, matrix metalloprotease-7 (MMP-7) and matrix-metalloprotease-9 (MMP-9). Subsequently, in order to detect the role of the hepatocytes in these changes seen in tumor cells, two models of co-culturing hepatocytes with CC531 cells were established. OPN, Runx2 and MMP-7 were found to be highly expressed in CC531 metastases explanted from the liver, but showed subsequent down-regulation and/or disappearance in cell culture. The inverse regulation of Hoxc8, OPN and Runx2 suggests that these genes may be regulated in a feed-back loop manner. MMP-9 mRNA and active MMP-7 protein were expressed in tumor cells themselves. The presence of hepatocytes was insufficient to induce induction of OPN and Runx2 in tumor cells in vitro, so was the addition of OPN or TGF-beta1. Whereas TGF-beta1 induced over-expression of OPN and Runx2 in hepatocytes, it did not exert the same effect on hepatocytes co-cultured with CC531 cells, indicating that this response was abrogated by CC531 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596651

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

2.  IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.

Authors:  Yan Chen; Ying Qin; Mengmeng Dai; Liping Liu; Yong Ni; Qinsheng Sun; Lulu Li; Yaoyao Zhou; Cheng Qiu; Yuyang Jiang
Journal:  Cancer Med       Date:  2021-05-13       Impact factor: 4.452

3.  Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis.

Authors:  Rania Georges; Frank Bergmann; Hadjar Hamdi; Michael Zepp; Ergül Eyol; Thomas Hielscher; Martin R Berger; Hassan Adwan
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

Review 4.  Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Authors:  Hassan Adwan; Rania Georges; Asim Pervaiz; Martin R Berger
Journal:  Front Oncol       Date:  2017-07-18       Impact factor: 6.244

Review 5.  Osteopontin b and c Splice isoforms in Leukemias and Solidzzm321990Tumors: Angiogenesis Alongside Chemoresistance

Authors:  Akram Mirzaei; Saeed Mohammadi; Seyed H Ghaffari; Marjan Yaghmaie; Mohammad Vaezi; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

6.  Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2.

Authors:  Fan-Chun Meng; Jun-Kai Lin
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.